Letters to the Editor

Cohn Jay B. (1981) Multicentre double blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients. Journal of Clinical Psychiatry, 42, 347–351.

Feighner J. P. Aden G. C. Fabre L. F. Rickels K. Smith W. J. (1983) Comparison of alprazolam, diazepam and placebo in the treatment of depression. J.A.M.A., June 10. Vol. 249 No. 22, 3057–3064.

Davidson K. Farquaarson R. G. Khan M. C. Majid A. (1983) A double blind comparison of alprazolam, diazepam, and placebo in the treatment of anxious outpatients. Psychopharmacology, 80, 308–310.

Maletzky B. M. (1980) Anxiolytic effect of alprazolam compared to diazepam and placebo. Journal of International Medical Research, 8, 139–143.

Molnar E. Evans L. (1983) The management of phobias. Patient Management, Feb. 23–25.

Sheehan D. B. (1982) Current perspectives in the treatment of panic and phobic disorder. Drug Therapy, September, 179–189.

Bennaheim Da Messner Rp Recent observations on central nervous system lupus erythematosus. Seminars in Arthritis and Rheumatism 1975;4: 253–266.

Feinglass Ej Arnett Fc Ca Dorsch Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine (Baltimore) 1976;55:323–339.

Lee P. Urowitz Mb Be Koehler Systemic lupus erythematosus. A review of 110 cases with reference to nephritis. Quarterly Journal of Medicine 1977;46: 1–32.

Hughes Grv Systemic lupus erythematosus: treatment and prognosis. British Medical Journal 1979; 1919–1922.

Liang Mh Meenan Rf Es Cathcart A screening strategy for population studies in systemic lupus erythematosus. Arthritis and Rheumatism 1980;23: 153–157.

Tan Em Cohen As Jf Fries The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis and Rheumatism 1982;25: 1271–1277.

Winfield Jb Cm Brunner Koffler D. Serologic studies in patients with systemic lupus erythematosus and central nervous system dysfunction. Arthritis and Rheumatism 1978;21: 289–294.

Winn Dm Wolfe Jf Da Lindberg Identification of a clinical subset of systemic lupus erythematosus by antibodies to the SM antigen. Arthritis and Rheumatism 1979;22: 1334–1337.

Hg Bluestein Zvaifler Nj Brain-reactive lymphocytotoxic antibodies in the serum of patients with systemic lupus erythematosus. Journal of Clinical Investigation 1976;57: 509–516.

Bresnihan B. Oliver M. Williams B. An antineuronal antibody cross-reacting with erythrocytes and lymphocytes in systemic lupus erythematosus. Arthritis and Rheumatism 1979;22: 313–320.

Miniter Mf Bd Stollar Agnello V. Reassessment of the clinical significance of native DNA antibodies in systemic lupus erythematosus. Arthritis and Rheumatism 1979;22: 959–968.

Ec Johnstone Whaley K. Antinuclear antibodies in psychiatric illness: their relationship to diagnosis and drug treatment. British Medical Journal 1975;2: 724–725.